• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D filed by Healthcare Triangle Inc.

    10/25/21 5:27:12 PM ET
    $HCTI
    EDP Services
    Technology
    Get the next $HCTI alert in real time by email
    SC 13D 1 hcti102521formsch13d.htm SC 13D
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, DC 20549

     

    SCHEDULE 13D

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

    (Amendment No.     )*

     

    Healthcare Triangle, Inc.

    (Name of Issuer)

    Common Stock

    (Title of Class of Securities)

     

    42227W 108

    (CUSIP Number)

     

    Suresh Venkatachari

    Chief Executive Officer

    4309 Hacienda Dr., Suite 150

    Pleasanton, California 94588

    Telephone: (925) 270-4812

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

    October 15, 2021

    (Date of Event Which Requires Filing of this Statement)

     

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.  ☐

     

     

    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

     

     

     

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     1 

     

     

    CUSIP No. 42227W 108   13D    

     

                 
      1.    

      Name of Reporting Persons

     

      SecureKloud Technologies, Inc.

      2.    

      Check the Appropriate Box if a Member of a Group (see instructions)

     

      (a) ☐  (1)      (b) ☒   

      3.    

      SEC USE ONLY

     

      4.    

      Source of Funds (see instructions)

     

      WC

      5.    

      Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)

     

      ☐

      6.    

      Citizenship or Place of Organization

     

      Nevada, USA

                 

    Number of

    Shares

      Beneficially  

    Owned by

    Each

    Reporting

    Person

    With

        7.    

      Sole Voting Power

     

      25,500,000 shares of Common Stock

      8.    

      Shared Voting Power

      0

      9.    

      Sole Dispositive Power

     

      25,500,000 of Common Stock

      10.    

      Shared Dispositive Power

     

      0

                 
    11.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      25,500,000 shares of Common Stock

    12.    

      Check if the Aggregate Amount in Row (11) Excludes Certain Shares (see instructions)

     

      ☐

    13.    

      Percent of Class Represented by Amount in Row 11

     

      63.29% (2)

    14.    

      Type of Reporting Person (see instructions)

     

      HC

     

    (1) This Schedule 13D is filed by SecureKloud Technologies, Inc., a Nevada corporation, which is the sole legal and beneficial owner of the shares of common stock of the Issuer as set forth herein. SecureKloud Technologies, Inc. is 65.2% owned by SecureKloud Technologies Ltd., which is a publicly traded company in India.

      

    (2) This percentage is calculated based on 37,738,750 shares of the Issuer’s Common Stock outstanding as of October 12, 2021as set forth in its Prospectus (File No. 333-259180) as filed under Rule 424(b)(4) with the Securities and Exchange Commission on October 14, 2021.

     

     2 

     

    Item 1. Security and Issuer.

     

    This statement on Schedule 13D relates to shares of common stock, par value $0.00001 per share (“Common Stock”), of Healthcare Triangle, Inc. (the “Issuer”). The Issuer is a corporation organized under the laws of the State of Delaware with principal executive offices at 4309 Hacienda Dr., Suite 150, Pleasanton, California 94588.

     

    Item 2. Identity and Background.

    SecureKloud Technologies, Inc. (the “Reporting Person”) is a corporation organized under the laws of the State of Nevada, with principal executive offices at 4309 Hacienda Dr., Suite 150, Pleasanton, California 94588.

    SecureKloud Technologies Ltd. (the “Parent”), the parent corporation of the Reporting Person, is a company organized under the laws of India, with principal executive offices at Srinivas Towers 2nd Floor, New No.5, Old No.11, 2nd Lane, Cenotaph Road, Austin Nagar, Teynampet, Chennai, Tamil Nadu 600018, India. Mr. Suresh Venkatachari is the Chairman and Chief Executive Officer of the Issuer, the Chief Executive Officer of the Reporting Person, is a director and the Chief Executive Officer of SecureKloud Technologies, Ltd. and owns 37% of SecureKloud Technologies, Ltd.

    The principal business of the Reporting Person and the Parent. is a global information technology business transformation, secure cloud solutions and managed services provider.

    The principal business of the Issuer is a healthcare information technology company focused on advancing innovative industry-transforming solutions in the sectors of cloud services, data science, and professional and managed services for the Healthcare and Life Sciences industry.

    The name, principal occupation, principal business address and citizenship of each director and executive officer of the Reporting Person and the Parent are as set forth on Schedule A.

    In the past five years, none of the Reporting Person or, to the knowledge of the Reporting Person, the Parent or any person listed on Schedule A, has: (i) been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or (ii) been a party to any civil proceeding of a judicial or administrative body of competent jurisdiction as a result of which it was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

    Item 3. Source and Amount of Funds or Other Consideration.

    In connection with a corporate reorganization conducted by the Reporting Person (“Reorganization”), on January 1, 2020, the Reporting Person transferred to the Issuer its Life Sciences business in exchange for 25,500,000 shares of the Issuer’s common stock, and on May 8, 2020, the Issuer acquired Cornerstone Advisors Group from the Reporting Person in exchange for the assumption of certain liabilities of the Reporting Person and the issuance of a $7,000,000 promissory note.

    Item 4. Purpose of the Transaction.

    The Reporting Person acquired the 25,500,000 newly issued shares of Common Stock pursuant to the Reorganization to provide the Issuer with operating business segments in order to expand the Issuer’s operations in the United States. On October 15, 2021 the Issuer closed its initial public offering raising approximately $13.0 million prior to deducting underwriting discounts, commissions, and offering expenses. The Reporting Person made no change in the Issuer’s board of directors or management in the Reorganization and has no plans or proposals to change the number or term of directors or to fill any existing vacancies on the board. The Reporting Person made no change in the Issuer’s capitalization (except for the change in the capitalization as a result of the Reorganization), dividend policy, business or corporate structure, charter, bylaws or securities, and has no plans to make any such change. The information set forth in Item 3 above is hereby incorporated by reference in response to this Item 4.

     3 

     

    Item 5. Interest in Securities of the Issuer

    The Reporting Person beneficially owns 25,500,000 shares of Common Stock, or approximately 63.29% of the outstanding shares of Common Stock as of October 12, 2021 based on 37,738,750 shares of the Issuer’s Common Stock outstanding as of October 12, 2021 as set forth in its Prospectus (File No. 333-259180) as filed under Rule 424(b)(4) with the Securities and Exchange Commission on October 14, 2021.

    The Reporting Person has the sole power to vote or direct the vote and to dispose or direct the disposition of such shares. The Reporting Person has not engaged in any transactions in the Common Stock during the past sixty days. Other than the Reporting Person, no person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Common Stock reported herein.

    Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.

    The Reporting Person is the “parent” corporation of the Issuer and, with its ownership of approximately 63.29% of the outstanding shares of Common Stock, has the power to elect all of the directors of the Issuer and to control all matters that would require the vote of a majority of the outstanding shares of Common Stock of the Issuer.

    In connection with the Reorganization conducted by the Reporting Person, on January 1, 2020, the Reporting Person and the Company entered into an Asset Transfer Agreement pursuant to which the Reporting Person transferred to the Issuer its Life Sciences business in exchange for 25,500,000 shares of the Issuer’s Common Stock On January 1, 2020, the Issuer and the Reporting Person entered into a Master Services Agreement, pursuant to which the Reporting Person agreed to develop software for the Issuer for fees negotiated in good faith that will be set forth in a separate statement of work for each software development project. The agreement has a two-year term, with automatic one-year renewals unless a party terminates at least 60 days prior to the end of the term.

    On January 1, 2020, the Issuer and the Reporting Person entered into a Shared Services Agreement, pursuant to which the Reporting Person will provide ongoing services to the Company that include infrastructure development, sales support, recruitment and immigration support, project coordination, human resources and operation support and management/advisory services. Under the agreement, the Reporting Person receives monthly compensation of $48,090. The term of the agreement is for two years and then continues on a month-to-month basis unless earlier terminated.

    On January 4, 2020, the Issuer and the Reporting Person entered into a Rental Sub-Lease Agreement, pursuant to which the Issuer subleases 3,500 square feet of office space from the Reporting Person for $8,500 per month. The term of the sublease is three years and renewable for two-year terms until cancelled by either party with 30 days’ notice.

    On May 8, 2020, the Issuer and the Reporting Person entered into an Equity Purchase Agreement pursuant to which, the Issuer acquired all of the equity of Cornerstone Advisors Group, LLC (“Cornerstone”) from the Reporting Person in return for a $7,000,000 Promissory Note, which has been repaid in full through the assumption of a $4,000,000 debt to Cornerstone owed by the Reporting Person (the “Cornerstone Debt”) and cash payments by the Issuer to the Reporting Person. The Issuer has repaid the Cornerstone Debt in full.

    Item 7. Material to Be Filed as Exhibits

     

    Exhibit No. Description
    1 Asset Transfer Agreement, dated January 1, 2020 between the Registrant and SecureKloud Technologies, Inc.
    2 Equity Purchase Agreement, dated May 8, 2020 between the Registrant and SecureKloud Technologies, Inc.
    3 Master Services Agreement dated January 1, 2020 between the Registrant and SecureKloud Technologies, Inc.
    4 Shared Services Agreement dated January 1, 2020 between the Registrant and SecureKloud Technologies, Inc.
    5 Rental Sublease Agreement dated January 4, 2020 between SecureKloud Technologies, Inc. and the Registrant.

     4 

     

     

    SIGNATURES

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated: October ___, 2021 SECUREKLOUD TECHNOLOGIES, INC.

    By: /s/ Suresh Venkatachari

    Name: Suresh Venkatachari

    Title: Chief Executive Officer

     

     5 

     

    Schedule A

    Reporting Person’s

    Directors and Executive Officers

    The business address for each director and executive officer of the Reporting Person is 4309 Hacienda Dr., Suite 150, Pleasanton, California 94588.

     

             

    Name

     

    Principal

    Occupation

      Citizenship
    Directors        
             
             
             
             
             
    Executive Officers        
             
             
             
             
             

     

    Parent’s

    Directors and Executive Officers

    The business address for each director and executive officer of the Reporting Person is Srinivas Towers 2nd Floor, New No.5, Old No.11, 2nd Lane, Cenotaph Road, Austin Nagar, Teynampet, Chennai, Tamil Nadu 600018, India.

     

             

    Name

     

    Principal

    Occupation

      Citizenship
    Directors        
             
             
             
             
             
    Executive Officers        
             
             
             
             
             

    Get the next $HCTI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HCTI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $HCTI
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Spartan Capital Securities, LLC Announces Key February Transactions

      New York, NY, March 07, 2025 (GLOBE NEWSWIRE) -- Spartan Capital Securities, LLC, a full-service investment banking firm, is pleased to announce a series of strategic transactions completed in February 2025, reinforcing its position as a trusted financial partner for companies across diverse industries. Spartan Capital successfully served as the sole placement agent for Lipella Pharmaceuticals Inc. (NASDAQ:LIPO) in a $3.788 million private placement. This financing represents an important milestone in Lipella's efforts to advance its clinical pipeline and address significant unmet medical needs under the leadership of CEO Dr. Jonathan Kaufman. The firm also played a key role as Co-Place

      3/7/25 4:56:47 PM ET
      $HCTI
      $LIPO
      EDP Services
      Technology
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Spartan Capital Securities, LLC Serves as Co-Placement Agent in Healthcare Triangle, Inc.'s $15.2 Million Private Placement

      New York, NY, March 04, 2025 (GLOBE NEWSWIRE) -- Spartan Capital Securities, LLC, a premier investment banking firm, is pleased to announce the successful completion of a $15.2 million private placement for Healthcare Triangle, Inc. (NASDAQ:HCTI). Spartan Capital Securities, LLC acted as Co-Placement Agent in this private offering, supporting Healthcare Triangle's continued expansion and digital transformation initiatives in the healthcare and life sciences industries. The proceeds from this offering will fund strategic acquisitions, general corporate purposes, and working capital needs, further advancing Healthcare Triangle's mission to deliver cutting-edge cloud enablement, cybersecuri

      3/4/25 8:55:00 AM ET
      $HCTI
      EDP Services
      Technology
    • Healthcare Triangle Announces Strategic Partnership with Cynomi to Enhance Cybersecurity in Healthcare

      PLEASANTON, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- Healthcare Triangle, Inc. (NASDAQ:HCTI) ("Healthcare Triangle," "HCTI" or the "Company"), a leading provider of healthcare IT solutions, is thrilled to announce its partnership with Cynomi, a pioneer vCISO platform vendor. This collaboration introduces an innovative Virtual Chief Information Security Officer (vCISO) service tailored specifically for the healthcare provider market, setting a new standard in cybersecurity and compliance. The vCISO platform, powered by Cynomi's cutting-edge AI technology, offers a comprehensive solution designed to continuously assess and enhance clients' cybersecurity and compliance posture. By implem

      4/4/24 8:00:00 AM ET
      $HCTI
      EDP Services
      Technology

    $HCTI
    SEC Filings

    See more
    • SEC Form 424B4 filed by Healthcare Triangle Inc.

      424B4 - Healthcare Triangle, Inc. (0001839285) (Filer)

      5/15/25 3:23:51 PM ET
      $HCTI
      EDP Services
      Technology
    • SEC Form EFFECT filed by Healthcare Triangle Inc.

      EFFECT - Healthcare Triangle, Inc. (0001839285) (Filer)

      5/15/25 12:15:33 AM ET
      $HCTI
      EDP Services
      Technology
    • SEC Form NT 10-Q filed by Healthcare Triangle Inc.

      NT 10-Q - Healthcare Triangle, Inc. (0001839285) (Filer)

      5/9/25 3:03:27 PM ET
      $HCTI
      EDP Services
      Technology

    $HCTI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by Healthcare Triangle Inc. (Amendment)

      SC 13D/A - Healthcare Triangle, Inc. (0001839285) (Subject)

      10/26/21 4:00:01 PM ET
      $HCTI
      EDP Services
      Technology
    • SEC Form SC 13D filed by Healthcare Triangle Inc.

      SC 13D - Healthcare Triangle, Inc. (0001839285) (Subject)

      10/25/21 5:27:12 PM ET
      $HCTI
      EDP Services
      Technology

    $HCTI
    Financials

    Live finance-specific insights

    See more
    • Healthcare Triangle, Inc. Releases Shareholder Update

      Highlights Market Opportunity and Recent Accretive Acquisition Awarded Top 100 Premier Partner Status at Amazon World Services & Premier Partner Status at Google Cloud PLEASANTON, Calif., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Healthcare Triangle Inc., (NASDAQ:HCTI) ("HCTI" or the "Company") a leading provider of cloud and data transformation platform and solutions for healthcare and life sciences, today released a shareholder update: Dear Shareholders: Thank you for your continued commitment and investment in Healthcare Triangle, Inc . Our progress over the past year would not have been possible without your trust and belief in our mission. This is our first shareholder update since our

      1/20/22 8:30:00 AM ET
      $HCTI
      EDP Services
      Technology
    • Healthcare Triangle (HCTI) Acquires DevCool, an Electronic Health Record (EHR) Focused Healthcare IT and Managed Services Company

      PLEASANTON, Calif., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Healthcare Triangle, Inc. (HCTI), a leading provider of Healthcare and Life Sciences cloud transformation, managed services and data analytics platform company, announced today that it has acquired DevCool, Inc. ("DevCool"), ranked by Inc. 5000 as among the fastest growing private companies in USA in 2021. DevCool provides EHR Implementation and Managed Services to 6 of the top 10 hospitals in the USA and specializes in providing services to cancer research hospitals and university medical centres. The combined entity will focus on accelerating healthcare providers to adopt cloud technologies in improving clinical, operational, and fin

      12/13/21 8:00:00 AM ET
      $HCTI
      EDP Services
      Technology

    $HCTI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Business Head Kannappan Lakshmanan acquired 304,180 shares, increasing direct ownership by 1,521% to 324,180 units (SEC Form 4)

      4 - Healthcare Triangle, Inc. (0001839285) (Issuer)

      4/2/25 5:13:23 PM ET
      $HCTI
      EDP Services
      Technology
    • Head of M&A Kizhakevilayil Shibu acquired 34,129 shares, increasing direct ownership by 171% to 54,129 units (SEC Form 4)

      4 - Healthcare Triangle, Inc. (0001839285) (Issuer)

      4/2/25 5:12:34 PM ET
      $HCTI
      EDP Services
      Technology
    • Chief Financial Officer Ramachandran Thyagarajan acquired 14,627 shares, increasing direct ownership by 98% to 29,627 units (SEC Form 4)

      4 - Healthcare Triangle, Inc. (0001839285) (Issuer)

      4/2/25 5:11:47 PM ET
      $HCTI
      EDP Services
      Technology

    $HCTI
    Leadership Updates

    Live Leadership Updates

    See more
    • Healthcare Triangle, Inc. Appoints Anand Kumar as Interim CEO

      PLEASANTON, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- Healthcare Triangle Inc. (NASDAQ:HCTI) ("Healthcare Triangle," "HCTI" or the "Company"), a frontrunner in healthcare technology has announced the appointment of Anand Kumar as the interim Chief Executive Officer alongside his current role as the Chief Revenue Officer. Anand is committed to leading the Company's continued commitment to driving innovation in Health Care through the utilization of Digital transformation, Artificial Intelligence (AI) and Large Language Models (LLM). With a wealth of experience and a track record of successfully leading initiatives, Anand is strategically positioned to guide HCTI through its next phase of

      3/12/24 9:41:00 AM ET
      $HCTI
      EDP Services
      Technology